glp-1 autoimmune disease Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune/autoinflammatory diseases | Cell & Bioscience Anti-inflammatory role of glucagon-like peptide

Diverticulosis of the colon is an acquired disease whose incidence increases with age, peaking after the 6th decade of life

Polycythaemia Vera: Treatment with B12 can mask the diagnosis of this blood disorder, so careful monitoring is necessary if B12 is started before a complete diagnosis

GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging

N-Acetyl Cysteine (NAC): L tin cht gip c th sn xut L-Glutathione, gip tng cng kh nng thi c v bo v gan

Harvard Toshniwal Paharia, Pooja Toshniwal Paharia